BTIG raises Treace Medical stock to Buy, sets $16 target
Concepts Inc (NASDAQ:TMCI) received an upgrade from BTIG, with analyst Ryan Zimmerman changing the stock rating from Neutral to Buy and setting a new price target of $16.00. This upgrade comes after a ...
BTIG Remains a Hold on Genco Shipping (GNK)
In a report released yesterday, Gregory Lewis from BTIG maintained a Hold rating on Genco Shipping (GNK – Research Report). The company’s ...
Treace Medical upgraded to Buy from Neutral at BTIG
BTIG analyst Ryan Zimmerman upgraded Treace Medical (TMCI) to Buy from Neutral with a $16 price target The company has pivoted away from ...
TMCnet22h
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
BTIG is a leading global financial services firm specializing in investment banking, institutional trading, research, and ...
TMCnet23h
InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference
For more information about the event, visit InMode's investor relations site here.
BTIG Research Estimates D.R. Horton’s Q4 Earnings (NYSE:DHI)
Research analysts at BTIG Research reduced their Q4 2025 earnings estimates for shares of D.R. Horton in a research note ...
BTIG maintains neutral PayPal stock rating amid growth concerns
BTIG analyst Lance Jessurun reaffirmed a Neutral rating on PayPal (NASDAQ:PYPL) stock, expressing caution ahead of the ...